Relationship Between Plasma Concentrations of Trazodone and Its Active Metabolite, m-Chlorophenylpiperazine, and Its Clinical Effect in Depressed Patients-Reference-Cited by-同舟云学术

Relationship Between Plasma Concentrations of Trazodone and Its Active Metabolite, m-Chlorophenylpiperazine, and Its Clinical Effect in Depressed Patients

Published:2002-08 Issue:4 Volume:24 Page:563-566
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:Therapeutic Drug Monitoring

Author:

Mihara Kazuo,Yasui-Furukori Norio,Kondo Tsuyoshi,Ishida Masayuki,Ono Shingo,Ohkubo Tadashi,Osanai Takako,Sugawara Kazunobu,Otani Koichi,Kaneko Sunao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference14 articles.

1. Trazodone

2. Pharmacology and Neurochemistry of Trazodone

3. Plasma levels of m-chlorophenylpiperazine following single oral dose administration of m-chlorophenylpiperazine and trazodone in human volunteers

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allosteric Inhibition and Pharmacochaperoning of the Serotonin Transporter by the Antidepressant Drugs Trazodone and Nefazodone;Molecular Pharmacology;2024-05-20

2. Analysis of Factors Affecting Concentrations and Concentration-To-Dose Ratios of Trazodone;Therapeutic Drug Monitoring;2024-01-26

3. The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants;Obesity Surgery;2023-03-22

4. The Structural and Optical Properties of 1,2,4-Triazolo[4,3-a]pyridine-3-amine;Molecules;2022-01-22

5. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants;The World Journal of Biological Psychiatry;2021-05-12